Literature DB >> 36210713

[MiR-125b-5 suppresses ovarian cancer cell migration and invasion by targeted downregulation of CD147].

Z Huang1, H Shen2, H Deng2, L Sun3, B Qü2.   

Abstract

OBJECTIVE: To investigate whether miR-125b-5p regulates biological behaviors of ovarian cancer cells by targeted regulation of CD147 expression.
METHODS: RT-qPCR was used to detect the expression of miR-125b-5p and CD147 mRNA in ovarian cancer tissues and cancer cell lines. SKOV3 cells transfected with miR-125b-5p mimic and HO8910 cells transfected with miR-125b-5p inhibitor were examined for changes in proliferation, migration and invasion using CCK-8 assay, colonyforming assay and Transwell assay. Starbase was used to predict the potential binding sites between miR-125b-5p and CD147, and double luciferase reporter gene assay was used to verify the targeting relationship. In SKOV3 cells, the effects of cotransfection with miR-125b-5p mimic and pcDNA3.1-CD147 (or pcDNA3.1) plasmid on cell proliferation, migration and invasion were assessed with CCK-8 assay and Transwell assay.
RESULTS: The expression of miR-125b-5p was significantly lowered and that of CD147 was increased in both ovarian cancer tissues and ovarian cancer cell lines (P < 0.05). Overexpression of miR-125b-5p in SKOV3 cells resulted in significantly suppressed cell proliferation, migration and invasion, while downregulation of miR-125b-5p in HO8910 cells promoted cell proliferation, migration and invasion. Bioinformatic analysis predicted that miR-125b-5p binds to CD147, which was confirmed by luciferase reporter gene assay. RT-qPCR and Western blotting showed that miR-125b-5p negatively regulated CD147 expression (P < 0.05). In SKOV3 cells, the inhibitory effects of miR-125b-5p mimic on cell proliferation, invasion and migration were significantly attenuated by co-transfection of the cells with pcDNA3.1-CD147 plasmid.
CONCLUSION: miR-125b-5p inhibits the migration and invasion of ovarian cancer cells by negatively regulating the expression of CD147.

Entities:  

Keywords:  CD147; invasion; miR-125b-5p; migration; ovarian cancer

Mesh:

Substances:

Year:  2022        PMID: 36210713      PMCID: PMC9550539          DOI: 10.12122/j.issn.1673-4254.2022.09.16

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  29 in total

1.  MicroRNA expression profiles in serous ovarian carcinoma.

Authors:  Eun Ji Nam; Heejei Yoon; Sang Wun Kim; Hoguen Kim; Young Tae Kim; Jae Hoon Kim; Jae Wook Kim; Sunghoon Kim
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

Review 2.  The many faces of EMMPRIN - roles in neuroinflammation.

Authors:  Smriti M Agrawal; V Wee Yong
Journal:  Biochim Biophys Acta       Date:  2010-07-30

3.  PPARγ inhibits ovarian cancer cells proliferation through upregulation of miR-125b.

Authors:  Shuang Luo; Jidong Wang; Ying Ma; Zhenwei Yao; Hongjuan Pan
Journal:  Biochem Biophys Res Commun       Date:  2015-05-02       Impact factor: 3.575

4.  MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.

Authors:  Nian-Sheng Lai; Qing-Sheng Dong; Hao Ding; Zeng-Li Miao; Yu-Chang Lin
Journal:  J Clin Neurosci       Date:  2013-09-11       Impact factor: 1.961

5.  Identification of microRNAome in rat bladder reveals miR-1949 as a potential inducer of bladder cancer following spinal cord injury.

Authors:  Tianyi Wang; Yong Liu; Wenqi Yuan; Liang Zhang; Yanjun Zhang; Zhijie Wang; Xianhu Zhou; Hengxing Zhou; Tianci Chu; Yan Hao; Bin Liu; Xuechao Zhao; Lu Lu; Shiqing Feng; Xiaohong Kong
Journal:  Mol Med Rep       Date:  2015-05-12       Impact factor: 2.952

6.  Olaparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer and a BRCA1 and/or BRCA2 mutation: SOLO1 China cohort.

Authors:  Lingying Wu; Jianqing Zhu; Rutie Yin; Xiaohua Wu; Ge Lou; Jing Wang; Yunong Gao; Beihua Kong; Xin Lu; Qi Zhou; Yueling Wang; Youguo Chen; Weiguo Lu; Wei Li; Ying Cheng; Jihong Liu; Xin Ma; Jing Zhang
Journal:  Gynecol Oncol       Date:  2020-11-27       Impact factor: 5.482

7.  MicroRNA signatures in human ovarian cancer.

Authors:  Marilena V Iorio; Rosa Visone; Gianpiero Di Leva; Valentina Donati; Fabio Petrocca; Patrizia Casalini; Cristian Taccioli; Stefano Volinia; Chang-Gong Liu; Hansjuerg Alder; George A Calin; Sylvie Ménard; Carlo M Croce
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

8.  Cancer statistics in China, 2015.

Authors:  Wanqing Chen; Rongshou Zheng; Peter D Baade; Siwei Zhang; Hongmei Zeng; Freddie Bray; Ahmedin Jemal; Xue Qin Yu; Jie He
Journal:  CA Cancer J Clin       Date:  2016-01-25       Impact factor: 508.702

Review 9.  Roles of Non-Coding RNAs in Normal Human Brain Development, Brain Tumor, and Neuropsychiatric Disorders.

Authors:  Jun-Hua Nie; Tian-Xiang Li; Xiao-Qin Zhang; Jia Liu
Journal:  Noncoding RNA       Date:  2019-04-30

10.  miR-125b-5p inhibits cell proliferation, migration, and invasion in hepatocellular carcinoma via targeting TXNRD1.

Authors:  Shengni Hua; Yingyao Quan; Meixiao Zhan; Huaxin Liao; Yong Li; Ligong Lu
Journal:  Cancer Cell Int       Date:  2019-07-30       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.